Category: Letter From the Editor
Letter From the Editor: Update on the Management of Pregnant Patients With Inflammatory Bowel Disease
What is new in the management of pregnant patients with inflammatory bowel disease (IBD)? This month’s issue of Gastroenterology & Hepatology explores recent developments involving diagnostics, […]
Letter From the Editor: Exploring the Disease Entity of MetALD
In 2023, MetALD was officially introduced as a disease entity, as part of a broader international, multisociety consensus process. MetALD is a new medical classification for […]
Letter From the Editor: Therapeutic Approaches for Disorders of Gut-Brain Interaction Other Than Medication
This month’s issue of Gastroenterology & Hepatology explores a wide array of current and emerging nonmedical approaches to the treatment of disorders of gut-brain interaction (DGBIs) […]
Letter From the Editor: Nutritional Management of Adult Patients Who Have Crohn’s Disease
How can we best approach the nutritional management of adult Crohn’s disease patients? This month’s issue of Gastroenterology & Hepatology features an Advances in IBD column […]
Letter From the Editor: The Evolving Concept of a Therapeutic Window of Opportunity for Crohn’s Disease
What is the therapeutic window of opportunity in patients with Crohn’s disease? This question is explored in a feature article in this month’s issue of Gastroenterology […]
Letter From the Editor: Spotlight on the Surveillance of Pouches
Is routine surveillance of a pouch always necessary? This question is explored in the Advances in IBD column in this month’s issue of Gastroenterology & Hepatology. […]
Letter From the Editor: The Evolving Field of Interventional Endoscopic Ultrasound
Has the field of interventional endoscopic ultrasound (EUS) reached a plateau? Professor Marc Giovannini, a pioneer of EUS-guided fine-needle aspiration and EUS-guided bilioduodenal anastomosis, attempts to […]
Letter From the Editor: Exploring Current and Emerging Therapies for Patients With Primary Biliary Cholangitis
Up to 40% of patients with primary biliary cholangitis (PBC) do not respond adequately to ursodeoxycholic acid, which is well established for first-line treatment. One of […]
Letter From the Editor: The Wave of Innovation in Endoscopic Bariatric and Metabolic Therapies
The field of endoscopic bariatric and metabolic therapies (EBMTs) is advancing rapidly. This month’s issue of Gastroenterology & Hepatology features an interview in our Advances in […]
Letter From the Editor: Examining the Use of Natural Products for the Treatment of Irritable Bowel Syndrome
Should natural products have a role in the management of patients with irritable bowel syndrome (IBS)? One of the feature articles in this month’s issue of […]
Letter From the Editor: Exploring the Use of Terlipressin in Candidates for Liver Transplant
Should terlipressin be used in liver transplant candidates? This question is explored in a feature article in this month’s issue of the journal Gastroenterology & Hepatology. […]
Letter From the Editor: Exploring Irritable Bowel Syndrome Symptoms in Patients With Inflammatory Bowel Disease
The prevalence of irritable bowel syndrome (IBS) symptoms in patients with inflammatory bowel disease (IBD) can vary greatly—from 11% to 64%, depending on the study population—and […]
Letter From the Editor: Examining Exercise in Metabolic Dysfunction-Associated Steatohepatitis
How and why should patients who have metabolic dysfunction-associated steatohepatitis (MASH) exercise? The MASH in Focus column in this month’s issue of Gastroenterology & Hepatology places […]
Letter From the Editor: Exploring the Use of Digital Therapeutics for Patients With Disorders of Gut-Brain Interaction
Can digital therapeutics such as apps help in the management of patients with disorders of gut-brain interaction? This question is explored in the Advances in IBS […]
Letter From the Editor: Female Representation in Advanced Endoscopy
Just two years ago, women accounted for less than 20% of the advanced fellows who received a match in the American Society for Gastrointestinal Endoscopy (ASGE) […]
Letter From the Editor: Exploring Screening for Colorectal Cancer
How can we best approach screening for colorectal cancer? This month’s issue of the journal Gastroenterology & Hepatology highlights screening for colorectal cancer, which remains one […]
Letter From the Editor: Examining the Use of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
Last month’s issue of the journal Gastroenterology & Hepatology delved into the use of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with inflammatory bowel disease (IBD). […]
Letter From the Editor: Exploring Glucagon-Like Peptide-1 Receptor Agonist Use in Inflammatory Bowel Disease Patients
The use of glucagon-like peptide-1 (GLP-1) receptor agonists is soaring in popularity to the point that these drugs are becoming household names. This month’s issue of […]
Letter From the Editor: Examining Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease Patients
Is there a role for using hyperbaric oxygen therapy to treat patients who have inflammatory bowel disease (IBD)? This month’s issue of Gastroenterology & Hepatology includes […]
Letter From the Editor: Exploring Alcohol Use Disorder and Alcohol-Associated Liver Disease
Alcohol-associated liver disease (ALD) is one of the most common causes of liver-related morbidity and death globally. Consuming alcohol elevates the risk of ALD development and […]
